Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novartis
ClinicalTrials.gov Identifier:
NCT00447694
First received: March 13, 2007
Last updated: September 22, 2016
Last verified: September 2016